Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats

Abstract

Taken together, our data demonstrate that the diabetogenic effect of chronic rapamycin administration is due to an impaired insulin action on glucose metabolism in skeletal muscles.